DS2330b Alone and With Sevelamer in Patients on Chronic Hemodialysis

NCT03305471 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperphosphatemia

Interventions

DRUG: DS-2330b PIB
DRUG: Placebo
DRUG: Sevelamer
DRUG: DS-2330b Tablet

Sponsor

Daiichi Sankyo